Raju Tejal A, Torjman Marc C, Goldberg Michael E
Department of Anesthesiology, Cooper University Hospital, The Robert Wood Johnson Medical School, UMDNJ, Camden, New Jersey 08103, USA.
J Diabetes Sci Technol. 2009 Nov 1;3(6):1282-7. doi: 10.1177/193229680900300607.
Several studies have shown a relationship between poor outcome and uncontrolled blood glucose (BG) in cardiac, neurosurgical, critical care, and general surgical patients. A major study showed that tight glycemic control (80-110mg/dl) was related to increased mortality. Based on evidence from controlled studies, the American Diabetes Association, and the Society of Thoracic Surgeons, maintaining intraoperative BG levels in the 140-180 mg/dl range seems appropriate. Optimization of the patient's preoperative medications and the use of insulin infusions, as well as surgical and anesthetic technique, are important factors for achieving desirable perioperative BG control. Minimizing BG variability during surgery should be part of the glycemic control strategy. Advances in real-time glucose monitoring may soon benefit hospitalized diabetes and nondiabetes patients.
多项研究表明,在心脏手术、神经外科手术、重症监护及普通外科手术患者中,预后不良与血糖(BG)控制不佳之间存在关联。一项大型研究表明,严格血糖控制(80 - 110mg/dl)与死亡率增加有关。基于对照研究、美国糖尿病协会及胸外科医师协会的证据,将术中血糖水平维持在140 - 180mg/dl范围内似乎是合适的。优化患者术前用药、使用胰岛素输注以及手术和麻醉技术,是实现理想围手术期血糖控制的重要因素。将手术期间血糖变异性降至最低应成为血糖控制策略的一部分。实时血糖监测技术的进步可能很快会使住院的糖尿病和非糖尿病患者受益。